Division of Cardiovascular Diseases:
Our Cardiac Amyloid experts specialize in the care of patients of both light chain amyloid (AL) and transthyretin amyloid (ATTR). All of our cardiologists are board certified advanced heart failure and transplant cardiologists, working in a multidisciplinary collaboration with evaluation by hematologists, neurologists and nephrologists. Using the latest advanced imaging techniques, such as nuclear medicine scans and cardiac MRIs, we have developed a streamlined approach to identification and diagnosis of this disease. With genetic testing, we can also assist patients in understanding how the disease may affect members of their family. We are actively researching these conditions and currently offer a number of therapies to manage cardiac amyloidosis, including a new drug developed through the efforts of the amyloid team at Scripps Research.